These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055 [TBL] [Abstract][Full Text] [Related]
7. [Cardiac resynchronization therapy: when the pacing site really matters]. García-Bolao I Rev Esp Cardiol; 2007 Feb; 60(2):97-100. PubMed ID: 17338873 [No Abstract] [Full Text] [Related]
8. Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. Lawo T; Borggrefe M; Butter C; Hindricks G; Schmidinger H; Mika Y; Burkhoff D; Pappone C; Sabbah HN J Am Coll Cardiol; 2005 Dec; 46(12):2229-36. PubMed ID: 16360051 [TBL] [Abstract][Full Text] [Related]
9. Survival and quality of life in patients with cardiac resynchronization therapy for severe heart failure and in heart transplant recipients within a contemporary heart failure management program. Becker M; Erdmann N; Stegemann E; Benke D; Schauerte PN; Schaefer WM; Autschbach R; Kelm M; Koch KC J Heart Lung Transplant; 2008 Jul; 27(7):746-52. PubMed ID: 18582804 [TBL] [Abstract][Full Text] [Related]
10. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. Tse HF; Siu CW; Lee KL; Fan K; Chan HW; Tang MO; Tsang V; Lee SW; Lau CP J Am Coll Cardiol; 2005 Dec; 46(12):2292-7. PubMed ID: 16360061 [TBL] [Abstract][Full Text] [Related]
11. [How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study]. García-Pinilla JM; Jiménez-Navarro MF; Anguita-Sánchez M; Martínez-Martínez A; Torres-Calvo F; Rev Esp Cardiol; 2007 Jan; 60(1):38-44. PubMed ID: 17288954 [TBL] [Abstract][Full Text] [Related]
12. Role of septal to posterior wall motion delay in cardiac resynchronization therapy. Pitzalis MV; Iacoviello M; Romito R; Luzzi G; Anaclerio M; Forleo C J Am Coll Cardiol; 2006 Aug; 48(3):596-7. PubMed ID: 16876000 [No Abstract] [Full Text] [Related]
13. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ; Raja SG; Salhiyyah K; Nagarajan K Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605 [TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy in patients with a narrow QRS complex. Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254 [TBL] [Abstract][Full Text] [Related]
15. There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure. Daubert JC; Leclercq C; Mabo P J Am Coll Cardiol; 2005 Dec; 46(12):2204-7. PubMed ID: 16360047 [TBL] [Abstract][Full Text] [Related]
16. Newfangled pacemaker helps with heart failure. Health News; 2002 Aug; 8(8):6. PubMed ID: 12206147 [No Abstract] [Full Text] [Related]
17. Why should we care about CARE-HF? Ellenbogen KA; Wood MA; Klein HU J Am Coll Cardiol; 2005 Dec; 46(12):2199-203. PubMed ID: 16360046 [TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold M; Abraham WT; Daubert JC; Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890 [TBL] [Abstract][Full Text] [Related]
19. Technology eases living with heart failure. New implantable devices, stem cell therapy, and monitoring techniques may improve length and quality of life. Health News; 2005 Feb; 11(2):7-8. PubMed ID: 15732151 [No Abstract] [Full Text] [Related]
20. The treatment of end-stage heart failure: does cardiac pacing have anything to offer? Chatoor R; Holt P Int J Clin Pract; 1999; 53(1):5-7. PubMed ID: 10344058 [No Abstract] [Full Text] [Related] [Next] [New Search]